Dual PTEN / p53 mRNA-Loaded Lipid Nanoparticles for Tumor Suppressor Restoration and Enhanced Antitumor Activity in PTEN-Null and TP53 Mutant Prostate Cancer

Abstract Messenger RNA (mRNA)-based therapeutics have emerged as a promising strategy for restoring disease-associated protein function without the risk of genomic integration. Although lipid nanoparticles (LNPs) enable efficient intracellular delivery of therapeutic mRNAs, most anticancer studies have focused on the restoration of a single tumor suppressor, which may be insufficient for tumors harboring concurrent deficiencies in multiple tumor suppressor pathways. Here, we developed a dual mRNA-loaded protopanaxadiol-derived lipid nanoparticle (PPD-LNP) platform coencapsulating PTEN and p53 mRNAs (PTEN/p53m-LNPs) to simultaneously restore two complementary tumor suppressor functions in PTEN/TP53-deficient PC-3 prostate cancer cells. Both therapeutic mRNAs were designed using the same proprietary 5′ and 3′ untranslated region (UTR) architecture to provide a common mRNA expression framework for PTEN and p53. Treatment with PTEN/p53m-LNPs restored both PTEN and p53 protein expression and markedly reduced phosphorylated AKT (Ser473), consistent with suppression of PI3K/AKT signaling. Furthermore, p53 restoration was accompanied by increased expression of the canonical p53 downstream targets p21 and MDM2, providing molecular evidence of functional p53 activity. Compared with either single-mRNA formulation, dual mRNA delivery produced greater inhibition of cell viability, reduced clonogenic colony formation by approximately 89%, and significantly suppressed cell migration and invasion. These findings demonstrate that codelivery of dual therapeutic mRNAs using a single PPD-LNP enables simultaneous restoration of complementary tumor suppressor functions and enhanced antitumor activity. This study provides a proof-of-concept for multi-mRNA tumor suppressor restoration in cancer cells with concurrent tumor suppressor deficiencies.

Authors

Institutions

Publication Details

Journal
ACS Bio & Med Chem Au
Published
2026-11-16
DOI
https://doi.org/10.1021/acsbiomedchemau.6c00177
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dual PTEN / p53 mRNA-Loaded Lipid Nanoparticles for Tumor Suppressor Restoration and Enhanced Antitumor Activity in PTEN-Null and TP53 Mutant Prostate Cancer

Seung-Yeul Lee, Han Sang Kim, Ha Yeon Park, Jae‐Wook Lee et al.
3 links
ACS Bio & Med Chem Au
RNA Interference and Gene Delivery
article

Dual PTEN / p53 mRNA-Loaded Lipid Nanoparticles for Tumor Suppressor Restoration and Enhanced Antitumor Activity in PTEN-Null and TP53 Mutant Prostate Cancer

Seung-Yeul Lee, Han Sang Kim, Ha Yeon Park, Jae‐Wook Lee, Sin A Park, Tae Jeong Oh, Jae Hoon Kim, Jun Hyeong Hong, Sunghwan An
article en

Abstract

Abstract Messenger RNA (mRNA)-based therapeutics have emerged as a promising strategy for restoring disease-associated protein function without the risk of genomic integration. Although lipid nanoparticles (LNPs) enable efficient intracellular delivery of therapeutic mRNAs, most anticancer studies have focused on the restoration of a single tumor suppressor, which may be insufficient for tumors harboring concurrent deficiencies in multiple tumor suppressor pathways. Here, we developed a dual mRNA-loaded protopanaxadiol-derived lipid nanoparticle (PPD-LNP) platform coencapsulating PTEN and p53 mRNAs (PTEN/p53m-LNPs) to simultaneously restore two complementary tumor suppressor functions in PTEN/TP53-deficient PC-3 prostate cancer cells. Both therapeutic mRNAs were designed using the same proprietary 5′ and 3′ untranslated region (UTR) architecture to provide a common mRNA expression framework for PTEN and p53. Treatment with PTEN/p53m-LNPs restored both PTEN and p53 protein expression and markedly reduced phosphorylated AKT (Ser473), consistent with suppression of PI3K/AKT signaling. Furthermore, p53 restoration was accompanied by increased expression of the canonical p53 downstream targets p21 and MDM2, providing molecular evidence of functional p53 activity. Compared with either single-mRNA formulation, dual mRNA delivery produced greater inhibition of cell viability, reduced clonogenic colony formation by approximately 89%, and significantly suppressed cell migration and invasion. These findings demonstrate that codelivery of dual therapeutic mRNAs using a single PPD-LNP enables simultaneous restoration of complementary tumor suppressor functions and enhanced antitumor activity. This study provides a proof-of-concept for multi-mRNA tumor suppressor restoration in cancer cells with concurrent tumor suppressor deficiencies.

ACS Bio & Med Chem Au
Yonsei University (KR)
Good health and well-being
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon